SEC Form D private-offering filing

Arpeggio Biosciences, Inc.

Name: Arpeggio Biosciences, Inc. - new SEC Form D private-offering filing, Boulder, CO
Published: 2025-11-24

A new SEC Form D private-offering notice from Boulder, CO, a $35,318,765 filer-stated offering target in Biotech. The source filing is one click away.

Arpeggio Biosciences, Inc. site↗ Verified via SEC Form D

Boulder biotech developing therapies for lung cancer and other diseases by targeting undruggable transcription factors, using an AI driven nascent RNA sequencing platform.

Filed 2025-11-24Filed to raise $35,318,765First money in 2025-11-12Raised so far $20,037,075HQ (as filed) Boulder, COSector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified arpeggiobio.com↗Named in the filing 7 executives & directors

Open this row on the live feed →More new filings in Colorado →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.